351 related articles for article (PubMed ID: 31292633)
1. Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium.
Barlow WE; Beaber EF; Geller BM; Kamineni A; Zheng Y; Haas JS; Chao CR; Rutter CM; Zauber AG; Sprague BL; Halm EA; Weaver DL; Chubak J; Doria-Rose VP; Kobrin S; Onega T; Quinn VP; Schapira MM; Tosteson ANA; Corley DA; Skinner CS; Schnall MD; Armstrong K; Wheeler CM; Silverberg MJ; Balasubramanian BA; Doubeni CA; McLerran D; Tiro JA
J Natl Cancer Inst; 2020 Mar; 112(3):238-246. PubMed ID: 31292633
[TBL] [Abstract][Full Text] [Related]
2. Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium.
Tosteson AN; Beaber EF; Tiro J; Kim J; McCarthy AM; Quinn VP; Doria-Rose VP; Wheeler CM; Barlow WE; Bronson M; Garcia M; Corley DA; Haas JS; Halm EA; Kamineni A; Rutter CM; Tosteson TD; Trentham-Dietz A; Weaver DL;
J Gen Intern Med; 2016 Apr; 31(4):372-9. PubMed ID: 26658934
[TBL] [Abstract][Full Text] [Related]
3. Unifying screening processes within the PROSPR consortium: a conceptual model for breast, cervical, and colorectal cancer screening.
Beaber EF; Kim JJ; Schapira MM; Tosteson AN; Zauber AG; Geiger AM; Kamineni A; Weaver DL; Tiro JA;
J Natl Cancer Inst; 2015 Jun; 107(6):djv120. PubMed ID: 25957378
[TBL] [Abstract][Full Text] [Related]
4. US women screen at low rates for both cervical and colorectal cancers than a single cancer: a cross-sectional population-based observational study.
Harper DM; Plegue M; Jimbo M; Sheinfeld Gorin S; Sen A
Elife; 2022 Jun; 11():. PubMed ID: 35762572
[TBL] [Abstract][Full Text] [Related]
5. National Breast, Cervical, and Colorectal Cancer Screening Use in Federally Qualified Health Centers.
Amboree TL; Montealegre JR; Parker SL; Garg A; Damgacioglu H; Schmeler KM; Chiao EY; Hill EG; Sonawane K; Deshmukh AA; Adsul P
JAMA Intern Med; 2024 Jun; 184(6):671-679. PubMed ID: 38683574
[TBL] [Abstract][Full Text] [Related]
6. Patient Navigation for Comprehensive Cancer Screening in High-Risk Patients Using a Population-Based Health Information Technology System: A Randomized Clinical Trial.
Percac-Lima S; Ashburner JM; Zai AH; Chang Y; Oo SA; Guimaraes E; Atlas SJ
JAMA Intern Med; 2016 Jul; 176(7):930-7. PubMed ID: 27273602
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of Leveraging Social Determinants of Health to Improve Breast, Cervical, and Colorectal Cancer Screening: A Systematic Review.
Mohan G; Chattopadhyay S
JAMA Oncol; 2020 Sep; 6(9):1434-1444. PubMed ID: 32556187
[TBL] [Abstract][Full Text] [Related]
8. Trends in Breast, Colorectal, and Cervical Cancer Incidence Following the Affordable Care Act: Implications for Cancer Screening.
Sun M; Cole AP; Lipsitz SL; Trinh QD
JAMA Oncol; 2018 Jan; 4(1):128-129. PubMed ID: 29098266
[TBL] [Abstract][Full Text] [Related]
9. Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study.
Rutter CM; Kim JJ; Meester RGS; Sprague BL; Burger EA; Zauber AG; Ergun MA; Campos NG; Doubeni CA; Trentham-Dietz A; Sy S; Alagoz O; Stout N; Lansdorp-Vogelaar I; Corley DA; Tosteson ANA
Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):158-164. PubMed ID: 29150480
[No Abstract] [Full Text] [Related]
10. Association of Neighborhood Measures of Social Determinants of Health With Breast, Cervical, and Colorectal Cancer Screening Rates in the US Midwest.
Kurani SS; McCoy RG; Lampman MA; Doubeni CA; Finney Rutten LJ; Inselman JW; Giblon RE; Bunkers KS; Stroebel RJ; Rushlow D; Chawla SS; Shah ND
JAMA Netw Open; 2020 Mar; 3(3):e200618. PubMed ID: 32150271
[TBL] [Abstract][Full Text] [Related]
11. The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea.
Park H; Seo SH; Park JH; Yoo SH; Keam B; Shin A
Epidemiol Health; 2022; 44():e2022053. PubMed ID: 35760396
[TBL] [Abstract][Full Text] [Related]
12. Breast, Cervical, and Colorectal Cancer Screening Adherence: Effect of Low Body Mass Index in Women.
Charkhchi P; Schabath MB; Carlos RC
J Womens Health (Larchmt); 2020 Jul; 29(7):996-1006. PubMed ID: 31928405
[No Abstract] [Full Text] [Related]
13. Capsule Commentary on Tosteson et al., Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium.
Kolade VO; Meseeha MG
J Gen Intern Med; 2016 Apr; 31(4):411. PubMed ID: 26857730
[No Abstract] [Full Text] [Related]
14. Cancer Screening Disparities Before and After the COVID-19 Pandemic.
Lofters AK; Wu F; Frymire E; Kiran T; Vahabi M; Green ME; Glazier RH
JAMA Netw Open; 2023 Nov; 6(11):e2343796. PubMed ID: 37983033
[TBL] [Abstract][Full Text] [Related]
15. Associations between sociodemographic factors and breast, cervical, and colorectal cancer screening in the United States.
Mondragón Márquez LI; Domínguez Bueso DL; González Ruiz LM; Liu JJ
Cancer Causes Control; 2023 Dec; 34(12):1073-1084. PubMed ID: 37486400
[TBL] [Abstract][Full Text] [Related]
16. The diffusion of screening programmes in Italy, year 2009.
Zappa M; Dardanoni G; Giorgi Rossi P; Grazzini G; Naldoni C; Paci E; Pirola ME; Pizzuti R; Segnan N; Zorzi M; Federici A
Epidemiol Prev; 2011; 35(5-6 Suppl 5):3-7. PubMed ID: 22166346
[TBL] [Abstract][Full Text] [Related]
17. Inadequate Systems to Support Breast and Cervical Cancer Screening in Primary Care Practice.
Schapira MM; Sprague BL; Klabunde CN; Tosteson AN; Bitton A; Chen JS; Beaber EF; Onega T; MacLean CD; Harris K; Howe K; Pearson L; Feldman S; Brawarsky P; Haas JS;
J Gen Intern Med; 2016 Oct; 31(10):1148-55. PubMed ID: 27251058
[TBL] [Abstract][Full Text] [Related]
18. Provider Attitudes and Screening Practices Following Changes in Breast and Cervical Cancer Screening Guidelines.
Haas JS; Sprague BL; Klabunde CN; Tosteson AN; Chen JS; Bitton A; Beaber EF; Onega T; Kim JJ; MacLean CD; Harris K; Yamartino P; Howe K; Pearson L; Feldman S; Brawarsky P; Schapira MM;
J Gen Intern Med; 2016 Jan; 31(1):52-9. PubMed ID: 26129780
[TBL] [Abstract][Full Text] [Related]
19. Socioeconomic and healthcare use-related determinants of cervical, breast and colorectal cancer screening practice in the French West Indies.
Menvielle G; Dugas J; Richard JB; Luce D
Eur J Cancer Prev; 2018 May; 27(3):269-273. PubMed ID: 27824663
[TBL] [Abstract][Full Text] [Related]
20. Correlates of non-adherence to breast, cervical, and colorectal cancer screening among screen-eligible women: a population-based cohort study in Ontario, Canada.
Vahabi M; Lofters AK; Kopp A; Glazier RH
Cancer Causes Control; 2021 Feb; 32(2):147-155. PubMed ID: 33392906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
